 JACKSON CENTER, PA ACCESSWIRE September 13, 2021 Halberd Corporation OTC PINK:HALB has successfully eradicated the primary building block of neurofibrillary tangles of Alzheimers Disease from test fluids in laboratory testing. Through its patented extracorporeal process in combination with its patent-pending laser eradication process, replication tests conducted at Youngstown State University YSU achieved virtually 100 elimination of the Phosphorylated Tau antigen, which is related to the onset and progression of Alzheimers Disease and other neurodegenerative diseases! 